Rueil Malmaison, France

Frederique Borzeix

This inventor holds 2 USPTO granted patents. Top assignees: Institut Francais Du Pe'trole, Sophor S.a.. Active years: 1998-2000.


% Patents Active = 100.0

Average Co-Inventor Count = 1.6

ph-index = 2

Forward Citations = 26(Granted Patents)


Company Filing History:


Years Active: 1998-2000

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Frederique Borzeix: Innovator in Cosmetic Science

Introduction

Frederique Borzeix is a notable inventor based in Rueil Malmaison, France. She has made significant contributions to the field of cosmetic science, particularly through her innovative use of sophorolipids. With a total of 2 patents, her work focuses on enhancing skin health and metabolism.

Latest Patents

Frederique Borzeix's latest patents include groundbreaking research on sophorolipids as stimulating agents for dermal fibroblast metabolism. This patent emphasizes the use of at least one sophorolipid in cosmetics to stimulate the metabolism of fibroblasts in the skin's dermis. It highlights the potential of these agents to restructure, repair, and tone the skin. Another patent addresses the use of sophorolipids to inhibit free radical formation, showcasing their protective properties in cosmetic applications.

Career Highlights

Throughout her career, Frederique has worked with esteemed organizations such as the Institut Français Du Pétrole and Sophor S.A. Her experience in these institutions has allowed her to develop and refine her innovative ideas in cosmetic formulations.

Collaborations

Frederique has collaborated with notable professionals in her field, including Gerard Hillion and Remy Marchal. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Frederique Borzeix stands out as a pioneering inventor in the realm of cosmetic science. Her innovative patents and collaborations reflect her commitment to enhancing skin health through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…